Status:
UNKNOWN
Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Conditions:
Sarcopenia
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The COVID-19 pandemic is having a devastating global impact, and older adults who experience it are at higher risk of death from the disease. However, survivors of the disease have a greater risk of s...
Detailed Description
Patients over 18 years of age who are admitted to the hospital and whose main diagnosis and reason for staying is COVID-19 pneumonia will be included. The prevalence of sarcopenia in hospitalized pati...
Eligibility Criteria
Inclusion
- Over 18 years old, men or women.
- Main diagnosis is pneumonia due to COVID-19
- Subjects who, after having received information about the design, the purposes of the project, the possible risks that may arise from it and who at any time may deny their collaboration, verbally grant their consent to participate in the study.
Exclusion
- Refusal of the patient to participate in the study.
- Present a malignant neoplasm in active phase except spino- or basal cell Ca in local stage
- Clinical situation of agony.
- Amputation of limb (s).
Key Trial Info
Start Date :
February 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2021
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04780126
Start Date
February 26 2021
End Date
May 31 2021
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Emergencias Isabel Zendal
Madrid, Spain, 28046